OAM
ANAC

Oxford Asset Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Oxford Asset Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-25,728
Closed -$1.38M – 993
2016
Q1 		$1.38M Buy
+25,728
New +$1.9M 0.04% 432
2015
Q3 		– Sell
-136,381
Closed -$10.6M – 835
2015
Q2 		$10.6M Sell
136,381
-164,836
-55% -$10.8M 0.29% 65
2015
Q1 		$17.4M Sell
301,217
-56,146
-16% -$2.38M 0.44% 33
2014
Q4 		$11.6M Sell
357,363
-73,432
-17% -$2.2M 0.26% 64
2014
Q3 		$10.6M Buy
430,795
+408,581
+1,839% +$8.3M 0.24% 83
2014
Q2 		$387K Sell
22,214
-45,895
-67% -$739K 0.01% 594
2014
Q1 		$1.36M Buy
+68,109
New +$1.32M 0.04% 424
2013
Q4 		– Sell
-19,394
Closed -$206K – 959
2013
Q3 		$206K Buy
+19,394
New +$170K ﹤0.01% 738

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Oxford Asset Management's ANAC Position: Q2 2016 in Review

Oxford Asset Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 25,728 shares — an estimated $1.38M sold.

Oxford Asset Management first reported a position in ANAC in Q3 2013 and held it in 8 quarters. The position peaked at $17.4M in Q1 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Oxford Asset Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Oxford Asset Management sold 25,728 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1.38M.
  • Oxford Asset Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 8 quarters.
  • Oxford Asset Management's ANACOR PHARMACEUTICALS INC COM position peaked at $17.4M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Oxford Asset Management's 13F filing for Q2 2016, filed 8 Aug 2016.